Zentalis Pharmaceuticals, Inc. financial data

Symbol
ZNTL on Nasdaq
Location
10275 Science Center Drive, Suite 200, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 735 % -6.75%
Debt-to-equity 28.2 % +16.5%
Return On Equity -51.6 % -16.7%
Return On Assets -40.3 % -13.1%
Operating Margin -681 % -25.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.1M shares +1.45%
Common Stock, Shares, Outstanding 72.1M shares +1.45%
Entity Public Float 232M USD -85.2%
Common Stock, Value, Issued 72K USD +1.41%
Weighted Average Number of Shares Outstanding, Basic 72M shares +1.34%
Weighted Average Number of Shares Outstanding, Diluted 72M shares +1.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 26.9M USD -33.8%
Research and Development Expense 125M USD -36.5%
General and Administrative Expense 73.6M USD +13.6%
Operating Income (Loss) -183M USD +17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.9M USD +69.5%
Income Tax Expense (Benefit) -232K USD -176%
Net Income (Loss) Attributable to Parent -163M USD +16.4%
Earnings Per Share, Basic -2 USD/shares +14.3%
Earnings Per Share, Diluted -2 USD/shares +14.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.6M USD +1.69%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 312M USD -29.1%
Deferred Income Tax Assets, Net 106K USD
Property, Plant and Equipment, Net 3.09M USD -42.2%
Operating Lease, Right-of-Use Asset 31.2M USD -6.87%
Goodwill 0 USD -100%
Assets 352M USD -28.5%
Accounts Payable, Current 3.72M USD -81.8%
Employee-related Liabilities, Current 7.5M USD +15.9%
Accrued Liabilities, Current 35.3M USD -23.7%
Liabilities, Current 39M USD -41.5%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 37.7M USD -8.78%
Other Liabilities, Noncurrent 500K USD -54.1%
Liabilities 77.2M USD -29.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 59K USD -57.9%
Retained Earnings (Accumulated Deficit) -1.13B USD -16.8%
Stockholders' Equity Attributable to Parent 274M USD -28.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 274M USD -28.3%
Liabilities and Equity 352M USD -28.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.6M USD +37.2%
Net Cash Provided by (Used in) Financing Activities 189K USD +2600%
Net Cash Provided by (Used in) Investing Activities 40.5M USD -34.2%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 72.1M shares +1.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.03M USD -16.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.2M USD +1.44%
Deferred Tax Assets, Valuation Allowance 247M USD +12.6%
Deferred Tax Assets, Gross 256M USD +11.5%
Operating Lease, Liability 41.3M USD -6.16%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -163M USD +16.1%
Lessee, Operating Lease, Liability, to be Paid 57.1M USD -10.3%
Property, Plant and Equipment, Gross 5.59M USD -37.7%
Operating Lease, Liability, Current 3.63M USD +33.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.45M USD +2.38%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.28M USD +7.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.8M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.76M USD +4.15%
Deferred Tax Assets, Operating Loss Carryforwards 98.5M USD +1.89%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 14.8M USD +251%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.93M USD +2.19%
Additional Paid in Capital 1.4B USD +4.06%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.06M USD -20.7%
Deferred Tax Assets, Net of Valuation Allowance 8.96M USD -13.6%
Share-based Payment Arrangement, Expense 54.5M USD +2.26%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%